NEWS
News Articles
Georgia Bio Names 2022 Golden Helix Award Winners
Clearside Biomedical’s Rafael Andino and The Georgia Institute of Technology’s Krishnendu Roy to be Honored with Top Award ATLANTA, GA (April 11, 2022) – Georgia Bio, the state’s life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th. Georgia Bio is pleased to announce the winners of the 2022 Golden…
Read MorePfizer to Acquire ReViral for Up to $525M, Expanding RSV Pipeline
Pfizer has agreed to acquire ReViral, a developer of antiviral therapeutics targeting respiratory syncytial virus (RSV), for up to $525 million, the companies said today, in a deal designed to meet the unmet need for RSV treatments by adding ReViral’s infectious disease pipeline and R&D capabilities to those of the buyer. Read full article here
Read MoreCMS Decision is an Enormous Setback for Alzheimer’s Patients and a Dangerous Infringement on FDA’s Scientific Autonomy
Patients will suffer because of this bureaucratic and unnecessary second-guessing of the FDA, says BIO CEO. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the Centers for Medicare and Medicaid Services’ (CMS’s) National Coverage Determination (NCD) to restrict coverage for drugs used to treat…
Read MoreMorehouse School of Medicine CEO asks ‘what’s possible’ when leading (Podcast)
Dr. Valerie Montgomery Rice’s background in research seems to come in handy as an academic healthcare administrator. Instead of testing theories and making discoveries in a laboratory, the president and CEO of Morehouse School of Medicine (MSM) is helping to uncover the potential of her employees. Read the full article and hear the podcast here
Read MorePortal Innovations Expands Venture Development Platform to Atlanta
NATIONAL EXPANSION STRATEGY WILL FUEL VENTURE PORTFOLIO GROWTH Atlanta (April 05, 2022) – Portal Innovations today announced the expansion of its premier life sciences-focused venture development engine to Atlanta, Georgia, where it will invest in and provide the critical resources that early-stage companies need to grow and scale. Portal employs a highly differentiated “Crafted Capital”…
Read MorePotential drug for Alzheimer’s disease could block early damage, MCG researcher says
Most drugs proposed for Alzheimer’s disease target the gunk that accumulates in the brains of patients but fail to take enough away to make a difference or improve outcomes, said the head of the new Alzheimer’s Therapeutics Discovery program at Medical College of Georgia. It would be better to target a mechanism much earlier in…
Read More